Status:
COMPLETED
Evaluating Scaleup of an Adapted Breast Cancer Early Diagnosis Program in Rwanda
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Partners in Health
Rwanda Biomedical Centre
Conditions:
Breast Cancer
Benign Breast Disease
Eligibility:
All Genders
Brief Summary
Breast cancer incidence is increasing in low- and middle-income countries (LMICs) and breast cancer mortality is high in these regions largely due to late stage diagnoses. This is true in the low-inco...
Detailed Description
Despite the Burera trial's promising results it was clear adaptations would be needed for real-world scaleup. The Burera intervention focused on breast health in isolation, hindering scalability in a ...
Eligibility Criteria
Inclusion
- All individuals who are evaluated for a breast concern or receive breast cancer screening through implementation of the nationally-led early detection programs
Exclusion
- None
Key Trial Info
Start Date :
July 31 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
2357 Patients enrolled
Trial Details
Trial ID
NCT05364138
Start Date
July 31 2023
End Date
December 31 2024
Last Update
February 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Partners in Health (Inshuti Mu Buzima)
Butaro, Rwanda